References
- Mammen EF. Coagulation abnormalities in liver disease. Hematol Oncol Clin North Am 1992;6:1247–57.
- Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800–9.
- Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat J-L. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995;346:865–8.
- Rapaport SI, Rao LVM. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992;12:1111–21.
- Bernstein DE, Jeffers L, Erhardtsen E, Reddy KR, Glazer S, Squiban P, et al. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology 1997;113:1930–7.
- de Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W, et al. Definitions, methodology and therapeutic strategies in portal hypertension: a Consensus Development Workshop, Baveno, Lake Maggiore, Italy, 5 and 6 April 1990. J Hepatol 1992;15:256–61.
- Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 1998;80:773–8.
- Erhardtsen E, Nony P, Dechavanne M, Ffrench P, Boissel JP, Hedner U. The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagul Fibrinolysis 1998;9:741–8.
- Papatheodoridis GV, Chung S, Keshav S, Pasi J, Burroughs AK. Correction of both prothrombin time and primary haemostasis with therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis. J Hepatol 1999;31:747–50.
- Kalicinski P, Kaminski A, Drewniak T, Ismail H, Szymczak M, Markiewicz M, et al.. Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII. Transplant Proc 1999;31:378–9.
- The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988;319:983–9.
- The PROVA study group. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: a randomized multicenter trial. Hepatol 1991; 14:1016–24.